Drug regulator urges medicine checks through Mehfooz Dawa app
“Pakistan’s drug regulator is urging consumers to use the Mehfooz Dawa app to verify medicine authenticity and prices through a barcode-based system.”
Key points
- Pakistan’s drug regulator is urging consumers to use the Mehfooz Dawa app to verify medicine authenticity and prices through a barcode-based system.
- The platform is part of the country’s pharmaceutical track-and-trace programme.
The Drug Regulatory Authority of Pakistan has urged consumers to use its Mehfooz Dawa application to check medicine authenticity and prices, as part of efforts to curb counterfeit and improperly supplied products.
The system allows users to scan a 2D barcode on a medicine pack and check product information through the regulator’s track-and-trace platform.
A spokesperson for the Ministry of National Health Services said the centralised pharmaceutical track-and-trace system became operational on October 9. The system is intended to help authorities follow medicine supply chains and identify products that may require recall after quality complaints.
The spokesperson said about 800 pharmaceutical companies and more than 90,000 medicines are registered with the regulator. Consumers are being advised to use the application before purchasing or using medicines where a scannable barcode is available.
The initiative is designed to give buyers a practical way to compare a product’s details and listed price with information in the official system. It does not replace medical advice, prescriptions or reporting suspected side effects to a healthcare professional.
The regulator has asked people to remain cautious when buying medicines and to use the official verification system to help reduce the risk of counterfeit, unregistered or incorrectly priced products.
Corrections & clarifications
Spot an inaccuracy or need more detail? Email connect@newsnexus24.com. Publication time is shown above.